Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/22/2009 | US20090263356 Anti-angiogenic composition comprising grain-derived component as active ingredient |
10/22/2009 | US20090263320 Peptide-Based Compounds |
10/22/2009 | CA2721670A1 3-phenylpyrazolo[5,1-b]thiazole compound |
10/22/2009 | CA2721595A1 Polymorphs of hydrochloride salt of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide andmethods of use therefor |
10/22/2009 | CA2721339A1 Activating agent for peroxisome proliferator activated receptor |
10/22/2009 | CA2721191A1 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
10/22/2009 | CA2720670A1 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use |
10/22/2009 | CA2719789A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
10/22/2009 | CA2719785A1 Ether benzylidene piperidine aryl carboxamide compounds |
10/22/2009 | CA2719784A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds |
10/22/2009 | CA2717087A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides |
10/22/2009 | CA2693001A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
10/21/2009 | EP2110141A1 Protective agent for retinal nerve or optic nerve |
10/21/2009 | EP2110134A1 Cocoa extract compounds and methods for making and using the same |
10/21/2009 | EP2110132A1 Use of deuterium oxide as elastase inhibitor |
10/21/2009 | EP2109610A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
10/21/2009 | EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
10/21/2009 | EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
10/21/2009 | EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
10/21/2009 | EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
10/21/2009 | EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
10/21/2009 | EP1423413B1 Peptidic compounds selectively binding to p-selectin |
10/21/2009 | EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors |
10/21/2009 | EP1322624B1 Arylalkane-sulfonamides having endothelin-antagonist activity |
10/21/2009 | EP1292680B1 Agonist anti-trk-c monoclonal antibodies |
10/21/2009 | EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
10/21/2009 | EP1207877B1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids |
10/21/2009 | EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances |
10/21/2009 | EP1162968B1 Epigallocatechin-gallate for inhibiting angiogenesis |
10/21/2009 | CN101563324A Spiro-piperidine derivatives |
10/21/2009 | CN101563106A Combination of nmda- receptor ligand and a compound with 5-HT6 receptor affinity |
10/21/2009 | CN101563102A Method of treating endothelial dysfunction |
10/21/2009 | CN101563097A Stem cell factor therapy for tissue injury |
10/21/2009 | CN101563091A Composition comprising crustacean gastrolith components and its use |
10/21/2009 | CN101560546A Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
10/21/2009 | CN101560478A Bacillus subtilis subso natto for producing natto kinase and application thereof |
10/21/2009 | CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
10/21/2009 | CN101560196A High-purity ranolazine and preparation method thereof |
10/21/2009 | CN101560178A Polysubstituted indoline compound, preparation method and medical application thereof |
10/21/2009 | CN101560177A Preparation method of atorvastatin calcium |
10/21/2009 | CN101559274A Health care running machine and method for processing felt thereon |
10/21/2009 | CN101559228A Pharmaceutical composition for treating chronic stable angina pectoris with hyperlipemia |
10/21/2009 | CN101559227A Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions |
10/21/2009 | CN101559212A Medicament for treating slow failure or arrhythmia and preparation method thereof |
10/21/2009 | CN101559206A Traditional Chinese medicine preparation for treating apoplexy and preparation technology thereof |
10/21/2009 | CN101559203A Chinese medicament preparation for treating angina pectoris |
10/21/2009 | CN101559197A Traditional Chinese medicine composition for curing bradyrhythmia |
10/21/2009 | CN101559185A External medicament for curing varicose vein of lower limbs |
10/21/2009 | CN101559182A Traditional Chinese medicine for treating hyperpiesis and preparation method |
10/21/2009 | CN101559179A Antihypertensive peptide composition |
10/21/2009 | CN101559176A Chinese materia medica preparation for lowering blood pressure |
10/21/2009 | CN101559173A Traditional Chinese medicine preparation for treating cerebral hemorrhage and preparation technology thereof |
10/21/2009 | CN101559162A Application of traditional Chinese medicine composition in preparing medicament for curing slow arrhythmia |
10/21/2009 | CN101559127A Traditional Chinese medicine ointment for treating stage II chemotherapy-induced phlebitis and preparation method |
10/21/2009 | CN101559114A Application of traditional Chinese medicine composition in preparing antihypoxic |
10/21/2009 | CN101559088A Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide |
10/21/2009 | CN101559066A Application of 2'-O-beta-L-galactopyranosyl orientin and composition in preparing medicaments for resisting myocardial ischemia |
10/21/2009 | CN101559065A Choerospondias extractive, preparation and application of phenol compound contained in choerospondias extractive |
10/21/2009 | CN101559043A Benzene sulfonic acid levo-amlodipine pill and preparation method thereof |
10/21/2009 | CN101559042A Compound double-layer tablet containing telmisartan and hydrochlorothiazide |
10/21/2009 | CN101558878A Teabag containing paeoniifolia for reducing blood pressure and lowering lipid and manufacturing method thereof |
10/21/2009 | CN101558875A Granule prepared by camellia chrysantha tea and preparation method thereof |
10/21/2009 | CN101558808A Soft capsule of camellia chrysantha tea and preparation method thereof |
10/21/2009 | CN100551921C Use of brasilein |
10/21/2009 | CN100551443C Nano carbon tube infusion agent preparation method |
10/21/2009 | CN100551442C Medicinal composition containing calcium passage paralysor and B family vitamin and its use |
10/21/2009 | CN100551423C A pure Chinese medicine preparation for decreasing blood pressure and resuming function of brain cell |
10/21/2009 | CN100551392C Decumbent corydalis Rhizome medicinal composition for treating cerebral thrombosis sequela and rheumatic arthritis |
10/21/2009 | CN100551387C Chinese medicine pillow capable of treating hypertension |
10/21/2009 | CN100551383C Chinese medicine preparation for treating heart disease |
10/21/2009 | CN100551374C Sterilization technology of prostadil fatty emulsion and method of determination |
10/21/2009 | CN100551372C A combination of medication and application in preparing medication for treating and preventing cardiovascular diseases and cerebrovascular disease |
10/21/2009 | CN100551364C Medicine use of 3 (3 nitryl-4-hydroxy)phenyl acrylate in preparing medicine for controlling xanthine oxidase |
10/21/2009 | CN100551276C Sugar-less buckwheat flavone beverage |
10/21/2009 | CN100551262C Method for producing dried noodles containing tu-chung and haw rich in natural active substances |
10/20/2009 | US7605274 precipitating crystalline form from solvent solution using water as an antisolvent |
10/20/2009 | US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
10/20/2009 | US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles |
10/20/2009 | US7605165 Phenylalanine derivatives |
10/20/2009 | US7605164 Compositions and methods for treating heart failure |
10/20/2009 | US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy |
10/20/2009 | US7605140 Endothelial growth factors; antiischemic agents; neovascularization |
10/20/2009 | US7604185 Generation of therapeutic microfoam |
10/20/2009 | CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
10/20/2009 | CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
10/20/2009 | CA2397591C Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
10/20/2009 | CA2393303C Meglumine salt of a specific quinolinecarboxylic acid compound |
10/20/2009 | CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
10/20/2009 | CA2380852C Tricyclic compounds having spiro union |
10/20/2009 | CA2378428C Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes |
10/20/2009 | CA2376894C Pharmaceutical composition comprising a protein and an ectoine |
10/20/2009 | CA2336909C Thiobenzimidazole derivatives which are useful as inhibitors of human chymase activity |
10/20/2009 | CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
10/15/2009 | WO2009126923A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof |
10/15/2009 | WO2009126725A1 Method of modulating neovascularization |
10/15/2009 | WO2009126659A1 Neutralization of gm-csf for the treatment of heart failure |
10/15/2009 | WO2009126527A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors |
10/15/2009 | WO2009125987A2 Pharmaceutical formulation |
10/15/2009 | WO2009125981A2 Pharmaceutical formulation |
10/15/2009 | WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers. |